Cheng Ying, Dai Xin, Yang Ti, Zhang Nan, Liu Zhenzhong, Jiang Yiguo
State Key Laboratory of Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, 510120, China.
Institute for Chemical Carcinogenesis, Guangzhou Medical University, Guangzhou 511436, China.
J Oncol. 2019 May 2;2019:2476175. doi: 10.1155/2019/2476175. eCollection 2019.
Angiogenesis plays a key role in the development and progression of lung cancer. Recent studies have found that tumor cells can stimulate angiogenesis by secreting exosomes, which contain many long noncoding RNAs (lncRNAs), some of which are important for the development of lung cancer. However, the roles and mechanisms of exosomal lncRNAs in lung cancer angiogenesis have not yet been reported. In this study, lung cancer in mice was induced by urethane; we found that growth arrest specific 5 (GAS5) was lowly expressed in the serum exosomes and lung cancer tissues of mice with lung cancer. And there was a significant positive correlation between GAS5 expression in serum exosomes and lung cancer tissues. Furthermore, GAS5 was lowly expressed in human lung cancer tissues, lung cancer cells, and cells culture supernatant exosomes. The exosomes of lung cancer cells promoted human umbilical vein endothelial cells (HUVECs) proliferation and tube formation and inhibited their apoptosis. GAS5 overexpression in lung cancer cells increased GAS5 level in cell culture supernatant exosomes. And the exosomes of lung cancer cells containing high GAS5 level inhibited HUVECs proliferation and tube formation and increased their apoptosis. In addition, we found that GAS5 competitively bound miRNA-29-3p with phosphatase and tensin homolog (PTEN), upregulating PTEN mRNA and protein expression, and inhibited level of phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha (PI3K) and serine/threonine kinase 1 (AKT) phosphorylation in HUVECs. Overall, our results suggest that exosomal GAS5 could be a new therapeutic target for lung cancer which inhibits angiogenesis.
血管生成在肺癌的发生和发展中起关键作用。最近的研究发现,肿瘤细胞可通过分泌外泌体来刺激血管生成,这些外泌体含有许多长链非编码RNA(lncRNA),其中一些对肺癌的发展很重要。然而,外泌体lncRNA在肺癌血管生成中的作用和机制尚未见报道。在本研究中,用乌拉坦诱导小鼠肺癌;我们发现生长停滞特异性5(GAS5)在肺癌小鼠的血清外泌体和肺癌组织中低表达。血清外泌体和肺癌组织中GAS5的表达之间存在显著正相关。此外,GAS5在人肺癌组织、肺癌细胞和细胞培养上清外泌体中低表达。肺癌细胞的外泌体促进人脐静脉内皮细胞(HUVECs)增殖和管腔形成,并抑制其凋亡。肺癌细胞中GAS5的过表达增加了细胞培养上清外泌体中GAS5的水平。而含有高GAS5水平的肺癌细胞外泌体抑制HUVECs增殖和管腔形成,并增加其凋亡。此外,我们发现GAS5与磷酸酶和张力蛋白同源物(PTEN)竞争性结合miRNA-29-3p,上调PTEN mRNA和蛋白表达,并抑制HUVECs中磷脂酰肌醇-4,5-二磷酸3-激酶催化亚基α(PI3K)和丝氨酸/苏氨酸激酶1(AKT)的磷酸化水平。总体而言,我们的结果表明,外泌体GAS5可能是抑制血管生成的肺癌新治疗靶点。